Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0.0336 0.0666666666666667 0.0768
Stock impact report

Novus Therapeutics to Present OP0201 Data at the 20th International Symposium on Recent Advances in Otitis Media

NOVUS THERAPEUTICS (NVUS) 
US:NASDAQ Investor Relations: ir.novustherapeutics.com/news-releases
Company Research Source: Business Wire
IRVINE, Calif.--(BUSINESS WIRE)-- Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced that data from OP0201 study C-002 will be presented during the 20th International Symposium on Recent Advances in Otitis Media, being held June 9-13, 2019 in Los Angeles, CA. Poster Title: A Phase 1 Safety Study of Repeated Doses of Intranasal OP0201 Metered Dose Inhaler Compared to Placebo in Healthy Adults: A Potential Treatment for Otitis Media Date/Time: Tuesday June 11, 2019 from 1:00 – 3:00 PM Location: Loews Hollywood Hotel, Los Angeles, California About Study C-002 Study C-002 was a phase 1 randomized, double-blind, placebo-controlled, parallel-group, dose-escalation clinical trial designed to evaluate Show less Read more
Impact Snapshot
Event Time:
NVUS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for NVUS alerts
Opt-in for
NVUS alerts

from News Quantified
Opt-in for
NVUS alerts

from News Quantified